BRIEF-EMA's CHMP Recommends Extension To Marketing Authorisation For Wegovy

AstraZeneca PLC
Merck & Co., Inc.
AbbVie, Inc.
Novan, Inc.

AstraZeneca PLC

AZN

0.00

Merck & Co., Inc.

MRK

0.00

AbbVie, Inc.

ABBV

0.00

Novan, Inc.

NOVN

0.00

May 22 (Reuters) - EMA's CHMP:

  • EMA'S CHMP: RECOMMENDED EXTENSION TO MARKETING AUTHORISATION FOR WEGOVY

  • CHMP: RECOMMENDS EXTENSION TO MARKETING AUTHORISATION FOR WEGOVY TO ADD DAILY ORAL TABLET AS ALTERNATIVE FORMULATION TO WEEKLY SUBCUTANEOUS INJECTIONS

  • EMA'S CHMP: RECOMMENDS GRANTING MARKETING AUTHORISATION FOR LIRAGLUTIDE STADA

  • EMA'S CHMP: JASCAYD RECEIVED POSITIVE OPINION FROM CHMP FOR TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS OR PROGRESSIVE PULMONARY FIBROSIS

  • EMA'S CHMP: RECOMMENDS EXTENSION OF THERAPEUTIC INDICATION FOR KEYTRUDA

  • EMA'S CHMP: WITHDRAWAL OF INITIAL MARKETING AUTHORISATION APPLICATION FOR ORBLID AND VEBLOCEMA

  • EMA'S CHMP: RECOMMENDS GRANTING MARKETING AUTHORISATION FOR ETCAMAH

  • EMA'S CHMP: RECOMMENDS EXTENSION OF THERAPEUTIC INDICATION FOR ENHERTU

  • EMA'S CHMP: RECOMMENDS GRANTING MARKETING AUTHORISATION FOR ABLYMICO

  • EMA'S CHMP: RECOMMENDS GRANTING CONDITIONAL MARKETING AUTHORISATION FOR VIJOICE

  • EMA'S CHMP: RECOMMENDS EXTENSION OF THERAPEUTIC INDICATION FOR MAVIRET

Further company coverage: [NOVOb.CO]


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.